Melinta Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

World News: . []

NEW HAVEN Conn Jan 03 2018 GLOBE NEWSWIRE -- Melinta Therapeutics NASDAQMLNT a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections today announced that Dan Wechsler President and Ch...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 12:00 GMT Wednesday 3rd January 2018

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us